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Abstract.  The  product  of the Saccharomyces  cere- 
visiae gene  CDC28,  a  protein  kinase  required  for initi- 
ation  of the cell division  cycle, was localized  within 
yeast cells.  By using  immunofluorescence  methods,  the 
CDC28 product  was shown to be primarily  cytoplas- 
mic  in distribution.  The  gene product  was localized 
largely  to the particulate  fraction by differential  cen- 
trifugation  after mechanical  disruption  in  aqueous 
buffers.  The particulate  association  was not affected by 
the presence of nonionic  detergent.  To refine this  lo- 
calization  further,  a  procedure  was developed for the 
preparation  of yeast cytoplasmic  matrices  which  re- 
semble the cytoskeletons of vertebrate  cells on the ba- 
sis of methodology,  immunochemistry,  and gross ultra- 
structure.  A  portion  of the  CDC28 product was found 
to be tightly associated with these detergent-insoluble 
cytoplasmic matrices  by both  immunoflourescence  and 
immunoblotting  procedures.  Although,  for technical 
reasons,  precise quantitation  was not possible,  it is es- 
timated  that  a  minimum  of 2-15 %  of the total  CDC28 
product pool  is involved in the association  with  the in- 
soluble matrix.  Alcohol dehydrogenase,  a  soluble cyto- 
plasmic  protein,  was found not to be associated with 
the cytoplasmic matrices  at any detectable level,  where- 
as,  in contrast,  ,o10--40%  of the total cellular  actin,  a 
bonafide cytoskeletal protein,  was present  in these 
structures.  The proportion  of CDC28 gene product  as- 
sociated  with the particulate  fraction,  and perhaps  the 
insoluble matrix,  appears  to be substantially  decreased 
during  the preparation  of spheroplasts. 
M 
UTATIONAL analysis of the cell division cycle in 
Saccharomyces cerevisiae has  revealed  that  cell 
cycle  events  require  the  expression  of  specific 
genes (12).  One cell cycle event of special relevance to the 
control  of division  has  been designated  "start"  (12).  Both 
genetic and physiological studies suggest that this event, oc- 
curring  in G1,  is a primary  regulatory event for cell cycle 
initiation (5, 6,  16, 30). Start mutants, conditionally incapa- 
ble  of  cell  cycle  initiation,  have  been  used  to  identify 
initiation-specific genes and, ultimately, their products (30). 
Using genetic and molecular methods,  it has been possible 
to isolate a number of start genes on recombinant plasmids 
and  subject them  and their  encoded products  to intensive 
analysis  (3,  23,  25,  27,  31-34).  The  rationale  for this  ap- 
proach is predicated upon the assumption that understanding 
how cell division is controlled will require detailed knowl- 
edge  of the  gene  products  that  function  in  the  process. 
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Temperature-sensitive  mutants  in  the  complementation 
group cdc28 are classical start mutants in that, at the permis- 
sive temperature,  they show normal  cell division behavior 
whereas, at elevated temperatures, they are incapable of initi- 
ating new cell cycles. Cells in the process of dividing prog- 
ress through the cell cycle until they reach start (12, 30). The 
lesion appears to be cell cycle-specific inasmuch as macro- 
molecular synthesis is unimpeded in arrested cells (16). The 
CDC28 gene was isolated from an S. cerevisiae recombinant 
plasmid  library  by transformational  complementation  of a 
cdc28 mutation (25).  Sequence analysis of the cloned gene 
provided a predicted primary structure for the CDC28 prod- 
uct and revealed that the latter shared homology with a num- 
ber of protein kinases (23). Using antisera prepared against 
the product of a chimeric gene containing part of the CDC28 
coding region, we have demonstrated that the CDC28 prod- 
uct does in fact possess protein  kinase  activity  (34).  This 
finding suggests that this protein may participate in control 
of cell division as part of a signaling pathway involving pro- 
tein phosphorylation events. At this time, the origins and ul- 
timate targets of such a signal are unknown. 
The purpose of the work reported here is to establish the 
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in the hope of elucidating the molecular components and cel- 
lular  organization  of division-related  signaling  in  yeast. 
First, we observed that the CDC28 gene product was local- 
ized primarily in the cytoplasm by immunofluorescence ex- 
periments  and  primarily  to  the  particulate  fraction  by 
differential centrifugation followed by immunoblotting. Pre- 
vious studies indicated that, in addition to cell cycle effects, 
cdc28 mutants showed aberrations in morphology and in or- 
ganellar  motility  and transmission  (9,  12,  30; our unpub- 
lished  observations).  These  phenotypes  are  suggestive of 
functions associated with the cytoskeleton in higher cells (2, 
13, 21, 38, 39, 42). We therefore sought to determine whether 
the CDC28 product was associated directly with the yeast 
cytoskeleton. Because the yeast cytoskeleton has not been ex- 
tensively characterized,  we proceeded by adapting method- 
ology developed for cytoskeletal analysis in vertebrate cells 
(13) for use with S. cerevisiae. During  the course of our 
studies we became aware of a similar approach being taken 
to isolate microtubule associated proteins from mitotic cells 
of S. cerevisiae (28). Although some similarities are clearly 
apparent,  we cannot be certain that the structures we have 
prepared are precisely analogous to vertebrate cytoskeletons. 
We, therefore, refer to them as detergent-insoluble cytoplas- 
mic matrices. The preparation of these structures and analy- 
sis of association of the CDC28 gene product with them is 
described. 
Materials and Methods 
Strains and Media 
All strains used in this study were derivatives of BF264-15D (MATa, leu2, 
trpl, adel, his3) (34).  A diploid derivative of BF264-15D, MMY13, and a 
diploid derivative of BF264-15D carrying the galactose-regulated  allele of 
the CDC28 gene, MMY53 (described below), were constructed by render- 
ing haploid cells homothallie by transient transformation with a plasmid 
containing the gene HO (15) and allowing  the transformant cultures to 
diploidize. Individual  cell clones were then screened for the ability to sporu- 
late to confirm that diploidiT~tion had occurred. 
Construction of a congenic diploid strain, MMY53, where the CDC28 
gene was placed under control of the regulatable GAL/promoter, is de- 
scribed in Fig. 2 (q.v.). The construction of the plasmid pFT1 was as fol- 
lows. A BamHl restriction site was introduced by oligonucleotide-directed 
mutagenesis (44)  10 base pairs upstream from the translation im'tiation 
codon of  the CDC28geneonplasmidYRp7'[CDC2&4]  (33)to form plasmid 
YPp7~CDC2&4(BamHI)].  A 4.4-kb )~oI-BglII  fragment of this plasmid 
containing the CDC28 coding region and the sequence conferring auto- 
nomous replication in yeast (ARS/) were removed,  and the plasmid was 
reclosed by treatment with DNA polymerase followed by joining of the 
resulting blunt ends using DNA ligase. This plasmid (YRp7'[CDC2&4(,~&oI- 
Bglff)]) contains 5"flanking sequences of the CDC28 coding region now ad- 
jacent to the yeast TRIP/gexte. A 4.0-kb BamHI-BgllI fragment of YRp7'- 
[CDC2&4(BamHI) l was then inserted into plasmid pBM258 (17) placing the 
CDC28 gene under control of the yeast GAL/(galactokinasc) promoter.  A 
4.1-kb EcoRI fragment from this plasmid containing the Ca4/.2-CDC28 hy- 
brid gene was inserted into an EcoRI site adjacent to the TRP1 gane of plas- 
mid YRtfI'[ CDC2&  40~oI-BgflI)  l to create plasmid pFT1. This plasmid, 
which contains both 5'- and Y-CDC28-flanldng sequences surrounding the 
CDC28 coding region under GALl control, served as a source of DNA for 
transformational gene conversion. 
Unless specified,  cells were grown in YEPD medium, containing 1% 
yeast extract/2  % BactopeptoneJ2 % glucose, supplemented with 50 mg each 
of adenine and uracil per liter. YEPGal, used when galacl~se was required 
as the sole carbon source, was the same as YEPD except that 2 % galactose 
was substituted for glucose.  Minimal medium has been described (11). 
Antibodies and Affinity Purification of  CDC28 IgG 
Anti-yeast alcohol dehydrogenase (ADH) x  and preimmune serum from the 
same rabbit were a gift of Dr. Jill Ferguson (8). Anti-yeast actin antiserum 
was a gift of Drs. Susan Brown (Research  Institute of Scripps Clinic) and 
John Priagle (University of Michigan). 
Preparation of anti-CDC28  product antiserum (anti-CDC28f) by im- 
munizing rabbits using an Escherichia coli f~-galactosidase-CDC28  product 
hybrid protein isolated from E. colihas been described previously (31). An- 
tibodies with specificity  for this fusion protein were affinity purified.  The 
fusion protein was gel purified  as had been described (31) by separating 
crude bacterial  lysate on preparative sodium dodecyl  sulfate (SDS)-poly- 
acrylamide gels and excising the appropriate  band after brief staining with 
Coomassie Brilliant Blue followed by brief  destaining with water. Whole gel 
slices were then sealed in dialysis tubing filled with Tris-glycinate running 
buffer  without SDS. A number of these sealed  gel slices  were then sub- 
merged simultaneously  in a  chamber containing the same buffer across 
which 250 V were applied for 2 h. The polyacrylamide  slices were then dis- 
carded and the eluted protein was dialyzed against 0.1 M ammonium bicar- 
bonate overnight.  The solution was  concentrated using a  concentration 
apparatus (Amicon Corp., Danvers, MA) and finally lyophilized. Approxi- 
mately 400 ~tg of protein was dissolved in 2 ml of 0.1 M NaHCO3, pH 8.3, 
0.5 M NaC1 by boiling for 2 min followed by centrifugation to remove in- 
soluble debris. This was then reacted  with 1 g of cyanogen bromide-acti- 
vated Sepharose 4B (Sigma Chemical Co., St. Louis, MO) as has been de- 
scribed by March et al. (24), yielding a 3.5-ml bed volume column. The 
column was washed with 10 vol of each of the following solutions in succes- 
sion: 4.5 M  MgCI2;  1 M NaCI,  0.1  M acetic  acid, pH 4.8;  1 M  NaCI, 
0A M NaHCO3, pH 7.6; phosphate-buffered  saline (PBS), pH 7.6. 3 ml of 
crude serum was then circulated  through the column at 23~  for 2 h. The 
column was then washed with 10 vol of the following solutions in succes- 
sion: PBS, pH 7.6; 1 M NaCI, 0.1 M acetic acid, pH 4.8; 1 M NaC1, 0.1 M 
NaHCO3, pH 7.6; PBS, pH 7.6. Bound antibodies were eluted by applying 
4.5 M  MgC12. When the high-salt front appeared, two column volumes 
were collected and dialyzed  against 0.14 M  NaC1 overnight at 4~  The 
affinity-purified fraction was then dialyzed against PBS and finally concen- 
trated to ,,ol ml using an Amicon concentration apparatus.  This gave an IgG 
solution of ,'o100 ~tg/ml as determined by comparison to a dilution series 
of normal rabbit IgG on SDS-polyacrylamide  gels. Normal rabbit IgG was 
used at this concentration for control experiments. 
Anti-CDC28  carboxy-terminal  antisera  (anti-CDC28~st_29s) was  di- 
rected against a synthetic octadecapeptide  (provided by Dr. Ralph Arling- 
haus, University of Texas, Houston) homologous to the predicted carboxy- 
terminal amino acid sequence of  the CDC28 gene product (23). This peptide 
was conjugated to keyhole limpet hemocyanin by glutaraldehyde  crosslink- 
ing. Briefly, 5 mg of keyhole limpet hemocyanin was mixed with 5 mg of 
peptide  in 0.25 M K2HPO4 buffer, pH Z2, to a total volume of 0.7 ml. 4 
gl of 25 % glutaraldehyde was added stepwise with shaking and the mixture 
was allowed to sit on ice for 30 rain. The reaction mixture was then dialyzed 
overnight against 50 mM sodium phosphate buffer, pH 6.0. The peptide- 
carrier conjugate (the equivalent of 0.5 mg of paptide) was solubilized  by" 
bringing to 1% SDS and heating to 65~  for 5 min and then was diluted 
10-fold in PBS. This solution was emulsified with an equal volume of either 
complete or incomplete Freund's adjuvant for the initial or subsequent injec- 
tions, respectively, and then used to immunize rabbits. Affinity purification 
of the anti-CDC282Sl_29s IgG was accomplished by the method described 
above except that the affinity matrix consisted of the carboxy-terminal  pep- 
tide conjugated  to cyanogen bromide-activated  Sepharose  4B. 
Both of the affinity-purified antisera (anti-CDC28r  and anti-CDC282sl_29s) 
react with a polypeptide of 34 kD on immunoblots (unpublished results). 
The discrepancy between the published molecular mass of the in vitro trans- 
lation product observed by immunoprecipitation with the anti-CDC28f an- 
tiserum (31) and that described here can be attributed solely to differences 
in  the  molecular  mass  standards  used  in  these  two  studies.  The 
anti-CDC282s~_~ antiserum is a higher titer antiserum and gives a sub- 
stantially  stronger signal on immunoblots. 
Eiectrophoresis and Immunoblotting 
Samples for electrophoresis  were prepared by suspending whole cells or cy- 
toplasmic matrices in an equal volume of twice-concentrated  gel sample 
1. Abbreviations used in this paper: ADH, alcohol dehydrogenase;  DAPI, 
4',6-diamidino-2-phenylindole. 
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0.45-mm glass beads (B. Braun Instruments, Burlingame, CA). The sam- 
ples were then boiled for 3 min and the glass beads and cellular debris were 
removed by centrifugation. The proteins were resolved on SDS polyacryl- 
amide gels (20) and either stained with Coomassie Brilliant Blue R or used 
for immunoblotting. 
lmmunoblotting experiments were performed as described (41). Nitro- 
cellulose was blocked overnight with 5% nonfat dry milk (Carnation) and 
5% bovine serum albumin (BSA) in Tris-buffered saline (20 mM Tris, pH 
7.5, 0.15 M NaCI) after eleetrophoretic transfer. Nitrocellulose strips were 
incubated overnight with anti-CDC2828~  z~8, anti-yeast alcohol dehydroge- 
nase or anti-yeast actin in Tris-buffered saline with I% BSA followed by 
L'5I-Protein A  (ICN  National  Biochemicals, Cleveland, OH)  or alkaline 
phosphatase-coupled goat anti-rabbit lgG (Promega Biotec, Madison, Wl) 
as indicated. Antisera were used at 1:200, 1:5,000, and 1:5,000, respectively. 
Strips were washed five times for 5 min in Tris-buffered saline after each 
antiserum incubation. Autoradiography was performed at -70  ~ with Kodak 
GPB film (Eastman Kodak Co., Rochester, NY) and a Cronex Lightning 
Plus intensifying screen, (DuPont Co., Wilmington, DE) or color develop- 
ment was performed according to the manufacturer's instructions. Quantita- 
tion of signals on immunoblots, where reported, was by densitometry using 
an Ultroscan XL laser densitometer (LKB Instruments, Inc., Gaithersburg, 
MD). 
Preparation of Cytoplasmic Matrices 
Cells were grown to an approximate density of 2-4  x  107/ml and  har- 
vested by centrifugation. Cells were then resuspended in one-tenth the origi- 
nal culture volume of wall removal buffer: 0.2 M Tris-HCI, pH 9.4, 0.02  M 
EDTA,  I% 2-mercaptoethanol. After 10 min at 23~  cells were collected 
by  centrifugation  and  resuspended  in  an  equivalent  volume  of YEPD 
medium stabilized with 1 M sorbitol and adjusted to 0.01 mg/ml chitinase 
(Sigma Chemical Co.), 0.02 mg/ml zymolyase (Kirin Brewery,  Tokyo, Ja- 
pan) and  1% glusulase (Endo Laboratories, New York).  Incubation was at 
30~  for 15-30 min. Wall removal was monitored as a function of suscepti- 
bility to lysis in 5% SDS. When cells became uniformly spheroplasted, they 
were collected by centrifugation at 23~  and washed once in stabilization 
buffer with  I  M  sorbitol.  Stabilization buffer is 0.15 M  Pipes, pH 6.9, 
0.1 mM  EGTA,  0.5  mM  MgCI2,  1 mM  phenylmethylsulfonyl chloride, 
containing pepstatin A and leupeptin at 1 gg/ml and aprotinin at 1:2,000 di- 
lution. Preparation of cytoplasmic matrices was essentially as described by 
Heuser and Kirschner (13). Spheroplasts were resuspended in one tenth the 
original  culture  volume of stabilization buffer with 0.2%  Triton  X-100, 
pelleted immediately, and resuspended in the same buffer with 0.1  mg/ml 
bovine pancreatic DNase I for 60 rain at 23~  Cytoplasmic matrices were 
then washed once by resuspension in stabilization buffer with Triton X-100 
followed by recentrifugation, and finally resuspended and washed twice in 
stabilization buffer without detergent. 
Fluorescence Microscopy of Yeast Cells 
and Cytoplasmic Matrices 
Approximately  109  log-phase cells were collected by  centrifugation and 
resuspended for 10 min in wall  removal  buffer (0.2  M Tris-HCI, pH 9.4, 
0.02  M  EDTA,  1%  2-mercaptoethanol), followed by  centrifugation and 
resuspension in stabilization buffer brought to 3.7%  formaldehyde. After 
fixation at 23~  for 30 min, cells were washed two times by centrifugation 
through stabilization buffer-I M sorbitol and then resuspended in 10 ml of 
stabilization buffer-I M sorbitol to which were added 150 Itg of zymolyase, 
50 I.tg of chitinase and 35 gl of glusulase. Incubation was for ,'~  min at 
23~  and permeabilization was monitored by loss of refractility when cells 
were suspended in an equal volume of 10% SDS. Spheroplasts were washed 
two times in stabilization buffer-1 M sorbitol and then resuspended in meth- 
anol at -20~  and incubated at that temperature for 5 min. After pelleting, 
the spheroplasts were resuspended in acetone at  -20~  and then pelleted 
immediately. After resuspension in PBS made 1 mg/ml with BSA (Sigma 
Chemical Co.;  Fraction V) (PBS-BSA),  fixed spberoplasts were divided 
among four  1.5-ml microfuge tubes for reaction with antisem. Each tube 
was used for a staining experiment. Pellets were resuspended in 20 I.tl of 
1:4 affinity-purified anti-CDC28f product IgG or 1:150 anti-ADH serum. 
All dilutions were with PBS-BSA. Reaction was for 1-2 h at 23~  Five 
washes were performed by resuspension of the cells in 1 ml of PBS-BSA 
followed by centrifugation for 1 s using an Eppendorf microfuge (Brinkmann 
Instruments Co., Westbury,  NY).  Pellets were then resuspended in 20 I.tl 
of 1:16 affinity-purified fluorescein-conjugated goat anti-rabbit IgG (Miles 
Laboratories, Inc., Naperville, IL). Incubation was for 1 h in the dark fol- 
lowed by five washes in PBS-BSA. Pellets were resuspended in 97% glyc- 
erol/3 % PBS containing the antibleaching agent p-phenylenediamine as de- 
scribed by Adams and Pringle (1). Samples at this point could be stored 
at  -20~  Samples were mounted and then observed and photographed 
using a  Zeiss Pbotomicroscope II fitted with epifluorescence and a  xl00 
Planapo oil  immersion objective.  Tri-X  Pan  film was developed using 
Diafine (Eastman Kodak Co.). Photomicrographs are shown at a magnifica- 
tion of ,x,l,500. 
Cytoplasmic matrices prepared as described were resuspended in metha- 
nol at -20~  and incubated for 5 min. After pelleting and resuspension in 
PBS-BSA, they were stained with antibodies as described for whole cells. 
Antibody-stained  cytoskeletons were then fixed by resuspension in stabiliza- 
tion buffer brought to 3.7%  formaldehyde and incubation for 30 min at 
23~  Alternatively,  cytoplasmic  matrices  without  methanol  extraction 
were stained for actin using rhodamine-phalloidin (Molecular Probes, Eu- 
gene, OR; 25 U/ml in PBS for I  h) or for DNA using 4',6-diamidino-2- 
phenylindole (DAPI)  (Sigma;  10  p.g/ml  for 30  min).  For staining with 
DAPI, matrices were prefixed in 3.7% formaldehyde for 15 min before addi- 
tion of the dye. In all cases, several washes in PBS-BSA were performed 
before mounting.  Mounting,  observation, and photography were as de- 
scribed for whole, fixed cells except that for phalloidin staining, n-propyl 
gallate at 0.2% was used in the mounting solution to retard photobleaehing. 
Electron Microscopy of Critical Point-dried 
Cytoplasmic Matrices 
Preparation of cytoplasmic matrices for electron microscopy (EM) was by 
procedures adapted from those developed for visualization of the three- 
dimensional structure of animal cell cytoskeletons (18, 43).  Cytoplasmic 
matrices prepared as described above were fixed by resuspension in stabili- 
zation buffer containing 3 % EM grade glutaraldehyde and then washed two 
times by centrifugation through Sorenson's phosphate buffer (pH 6.8). Fixed 
matrices were then resuspended in the same buffer containing 1% OsO4 for 
1 h followed by two washes in buffer without OsO4 and one wash with wa- 
ter. The matrices were then placed on Formvar-coated grids which had been 
previously coated with 0.1% poly-L-lysine and allowed to settle by gravity. 
The grids were then dehydrated by submersion in water followed by a graded 
ethanol series (30%, 50%, 70%, 90%, and three changes of 100%) for 5 
rain each. It is critical that the cytoplasmic matrices not dry at any point 
during the procedure as this results in a collapse of the three-dimensional 
structure. Staining of the matrices was achieved by including 1% uranyl ace- 
tate in the 70% ethanol used in the graded ethanol series. The three 100% 
ethanol washes were followed by critical point drying in a Samdra-78 dryer 
(Tousimis Research Corp., Rockville, MD).  The resulting critical-point- 
dried cytoplasmic matrices were photographed by transmission EM at the 
magnifications indicated in the figure legends. 
Results 
Localization of  CDC28 Product in Whole Cells 
We first sought to determine the location of the CDC28prod- 
uct by immunofluorescence in whole, fixed yeast cells. A 
diploid strain was chosen for these experiments rather than 
a haploid strain in order to exploit the larger cell size for 
resolution of detail.  Fig.  1,  a  and b  shows  fuorescence 
micrographs of diploid cells stained with anfi-CDC28f prod- 
uct IgG and an equivalent concentration of normal rabbit 
IgG, respectively. A general cytoplasmic staining pattern was 
observed using anti-CDC28f product IgG (a) but not in the 
control panel (b). To insure that the IgG was reactive specif- 
ically with the CDC28 gene product and not another immu- 
nologically cross-reactive  species,  two  additional control 
experiments  were  performed.  A  congenic  diploid  strain 
where the CDC28  gene had been placed under control of the 
inducible yeast GAL/promoter was used. The methodology 
used  to  construct this  strain  is  presented  in  Fig.  2  (see 
Wittenberg et al. Subcellular Localization  of the CDC28 Gene Product  1529 Figure L Immunofluorescence staining of fixed yeast cells. (a) Normal diploid cells (MMY13) stained with affinity-purified  anti-CDC28 
product IgG. (b) Same cells stained with equivalent concentration of  normal rabbit IgG. (c) Diploid cells with CDC28  under GAL/promoter 
control (MMY53) grown in galactose medium and stained with anti-CDC28 product IgG. (d) Same cells shifted to glucose medium for 
36 h prior to staining with anti-CDC28 product IgG. (e) Normal diploid cells stained with anti-yeast alcohol dehydrogenase serum. (f) 
Same cells stained with preimmune serum.  (g) MMY53 (galactose-regulated CDC28 allele) grown in galactose medium stained with 
anti-ADH serum. (h) MMY53 shifted to glucose medium for 36 h prior to staining with anti-ADH serum. For both the CDC28 product 
and ADH series, the exposure time was automatically set for normal diploid cells stained with immune sera. All other exposures in each 
series were manually normalized to this time. The second antibody in each case was fluorescein-conjugated (FITC) affinity-purified  goat 
anti-rabbit  IgG. Bars,  10 lxm. 
Materials and Methods). When these cells are grown with 
galactose as the sole carbon source, they contain ,'o100 times 
the wild-type level of CDC28 product based on both den- 
sitometry of immunoblots and biological activity (the ability 
to support cell division).  These results are predicted by a 
comparison of the estimated efliciencies of the CDC28 and 
GAL/promoters (31, 40). When cells are shifted to medium 
containing glucose as the sole carbon source, synthesis of 
CDC28 mRNA is terminated, and the preexisting protein is 
expected to be lost by turnover and dilution. The latter is 
confirmed because the cells cease dividing and become ex- 
tremely morphologically aberrant after approximately seven 
generations of growth on glucose (data not shown). Anti- 
CDC28f product staining of cells in the overexpression and 
"depleted" states described above is compared to staining of 
normal wild-type cells in Fig.  1, c and d, respectively. As 
can  be  seen,  galactose-grown cells  stain  much  more  in- 
tensely  than  the  normal  diploid  whereas  glucose-shifted 
cells,  although at least  10 times larger than normal cells, 
show little staining at all. To substantiate that the differences 
observed were not a staining artifact attributable to diverse 
metabolic states of the cells under the various growth condi- 
tions, preparations of the same cells shown in Fig.  1, a-d 
were stained with anti-yeast ADH antiserum (Fig.  1, e, g, 
and h) and preimmune serum (Fig.  1). It is not anticipated 
that levels of ADH should change substantially and this is 
confirmed. In the case of glucose-shifted CDC28-depleted 
cultures most of the alcohol dehydrogenase staining appears 
to be localized near the ends of the rod-shaped cells.  Al- 
though the reason for this is not known, it is conceivable that 
the rest of the cell in this terminal state consists mostly of 
endolytic vacuoles. The fact that the increase in anti-CDC28 
product immunofluorescence signal is not proportional to the 
extent of increase in CDC28 gene expression observed in the 
presence of galactose can be explained by the semiquantita- 
five  nature  of  immunofluorescence.  The  immunofluores- 
cence signal is not expected to increase in a linear fashion 
over a  100-fold  range of antigen concentration. Based on 
these observations, we conclude that the CDC28 product is 
primarily cytoplasmic in its distribution. 
To determine whether the CDC28 gene product is  in a 
particulate or a  soluble form, differential centrifugation of 
whole-cell lysates was performed. Cells were mechanically 
disrupted  by vortexing with  glass  beads  in  50  mM  Tris, 
pH 7.0. Cell lysis was determined to be >99 % by micro- 
scopic examination. Particulate fractions were prepared by 
sedimentation at 5,000, 20,000, or 100,000 g. These fractions, 
as well as the soluble supernatant fraction, were examined 
by  immunoblotting  for the  presence of the  CDC28 gene 
product (Fig.  3,  top panel,  lanes  1-4,  respectively). The 
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Figure 2. Construction of  a yeast strain in which CDC28  expression 
is regulated in response to carbon source. The construction of the 
plasmid pFT1, carrying the CDC28 gene under control of the yeast 
galactose promoter,  is described  in Materials  and Methods.  The 
galactose inducible allele of CDC28 was then inserted into haploid 
yeast strain BF264-15D (33) in place of the endogenous  CDC28 
gene by fragment-mediated transformation (35) with a 3.1-kb  NcoI- 
PvulI fragment  from the plasmid,  pFT1. The 3.1  kb NcoI-PvulI 
fragment  from plasmid  pFT1 carries  the  5' flanking  region  of 
CDC28, the yeast TRP1 gene capable of complementing a trpl mu- 
tation,  the CDC28 coding region under control of the GAL/pro- 
moter and the 3' flanking region of CDC28. Transformants were 
selected on the basis of the conversion of the tryptophan auxotroph 
BF264-15D to prototrophy  (37). The structure  of the  wild-type 
CDC28 locus  is  depicted  as  well  as  the  structure  of the  chro- 
mosomal locus  after gene conversion by the galactose-inducible 
CDC28 fragment.  The diploid  derivative of the  resulting  strain 
(MMY53) was constructed as described in Materials and Methods. 
The solid single lines represent pBR322 DNA sequences, double 
lines represent yeast DNA sequences, and bold lines represent yeast 
protein-coding regions.  The dashed lines represent  chromosomal 
DNA sequences.  Restriction  endonuclease  cleavage sites are de- 
noted as follows: B, BamHI, C, SacI, E, EcoRI, G, BgllI; N, NcoI; 
P, PstI; S, Sau3A; V, PvulI; X, XhoI. Standard procedures were em- 
ployed for manipulation of DNA. 
presence of alcohol dehydrogenase was also monitored as a 
control for efficient lysis and washing (bottom panel, lanes 
1-4,  respectively).  Greater than 70%  of the  gene product 
sediments in the 5,000- and 20,000-g fractions, with <20% 
in either the 100,000-g  pellet or the soluble supernatant.  In 
contrast, the pellet fractions are devoid of detectable soluble 
Figure 3. Analysis of CDC28  gene product associated with particu- 
late and soluble  fractions  of mechanically  disrupted  ceils.  Cells 
were disrupted by vortexing with glass beads either in 50 mM Tris, 
pH 7.0, on ice (lanes 1-4) or in stabilization buffer containing 0.2% 
Triton X-100 at 23~  (lanes 5-8). Each cell lysate was then frac- 
tionated by consecutive centrifugations at 5,000 g for 7 min (lanes 
1 and 5), 20,000 g for 30 min (lanes 2 and 6), and 100,000 g for 
90 min (lanes 3 and 7). Each pellet was washed once by resuspen- 
sion in the same buffer followed by recentrifugation  at the same 
velocity. The proteins  in the pellet  fractions  and  the  remaining 
supernatant fractions (lanes 4 and 8) were solubilized in SDS-poly- 
acrylamide gel electrophoresis sample buffer and separated by elec- 
trophoresis  through  a  4%/8.5%  discontinuous  SDS-polyacryl- 
amide  gel  followed by immunoblotting  using  anti-CDC28281-298 
antiserum (upper  panel) or anti-ADH antiserum (lower  panel). All 
lanes represent the material from 2  x  107 cells. Molecular weight 
markers are actin and carbonic anhydrase. Molecular weights given 
are  xl0  -3. 
protein as judged by the absence of ADH. This confirms that 
these  fractions  do  not  contain  an  appreciable number  of 
unlysed cells or trapped soluble protein.  Furthermore,  the 
CDC28 gene product associated with the 5,000- and 20,000-g 
pellets is not released when the pellet is washed with  1.0% 
Triton X-100 (not shown), suggesting that it is not associated 
with membrane. In fact, when the same fractionation scheme 
is performed using a buffer commonly used for the prepara- 
tion of vertebrate cytoskeletons (discussed below), contain- 
ing 0.2% Triton X-100 for the disruption of cellular and or- 
ganellar membranes,  a  similar result is  observed (Fig.  3, 
lanes 5-8).  The only qualitative difference in these results 
is the absence of the CDC28 product in the  100,000-g  frac- 
tion (lane 7) and the possibility of a slight amount of contam- 
ination with soluble protein in the 20,000-g fraction (lane 6). 
These same results are observed when Triton-X100 is absent 
from the buffer (data not shown).  We conclude that under 
each  of these  conditions  the  CDC28  gene  product  is  as- 
sociated with particulate, nonmembranous structures. In ad- 
dition,  because  most  of  the  ribosomes  sediment  in  the 
100,000-g  fraction (36), it is doubtful that a significant por- 
tion  of this particulate  CDC28 gene product is ribosome- 
associated, 
Preparation of  Detergent-insoluble 
Cytoplasmic Matrices 
Considering  the  general cytoplasmic staining  observed by 
immunofluorescence experiments along with localization to 
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toplasmic matrices.  Cells were sphero- 
plasted and extracted with detergent as 
described.  Cytoplasmic  matrix,  whole 
spheroplast,  and extraction supernatant 
fractions were homogenized by vortex- 
ing with glass beads and boiled in SDS- 
polyacrylamide gel sample buffer prior 
to electrophoresis  through  a 4%/8.5% 
discontinuous SDS-polyacrylamide gel. 
The gel was then stained with Coomas- 
sic Brilliant Blue R, destained, and pho- 
tographed. Lanes 2, 3, and 4 correspond 
to  cell  number  equivalents  (approxi- 
mately 1 x  107 cells/sample) of sphero- 
plast, extraction supernatant, and matrix 
fractions,  respectively.  Lane  1  corre- 
sponds to matrix fraction proteins from 
10 times as many cells as the other lanes. 
(B) Analysis of cytoplasmic matrix com- 
ponents by immunoblotting. Sample prep- 
aration,  electrophoresis,  and  immuno- 
blotting were as described.  Whole cell 
and  cytoplasmic  matrix samples  (2  x 
10  7 and 6  x  10  7 cells/lane, respectively) 
were stained with anti-yeast actin (lanes 
1 and 2, respectively) or anti-yeast ADH 
(lanes 3 and 4, respectively). The ADH 
signal was intentionally overexposed to 
emphasize  the absence  of ADH in the 
cytoplasmic matrices. Molecular weight 
standards are phosphorylase b, BSA, ac- 
tin, carbonic anhydrase, and saybean tryp- 
sin inhibitor. Values given are  xl0  -3. 
the particulate fraction in cell lysates, we chose to examine 
the yeast cytoplasmic matrix as a potential site of association 
of the CDC28 gene product. In vertebrate cells, the cytoplas- 
mic matrix or cytoskeleton is defined as the residual structure 
after detergent extraction of cells (4,  13, 22, 43). Adaptation 
of the methods used with vertebrate cells for use with yeast 
required several important modifications. First, because in- 
tact yeast cells are resistant to detergent extractions as a re- 
sult of a dense protective cell wall, enzymatic pretreatment 
is required. We found that after a short treatment with a mix- 
ture  of several hydrolytic enzymes,  the  cells,  presumably 
now spheroplasts, became accessible to extraction with de- 
tergent. This was the case even though, based on both light 
and electron microscopy, the ceils were still mostly encased 
in a matrix of, now presumably porous, cell wall material. 
Next, because yeast cells do not attach to a  substratum, as 
do most vertebrate cells used in cytoskeletal studies, a prin- 
cipal modification involved the use of centrifugation to per- 
form detergent washes and other extractions.  Here, the re- 
maining  cell  wall  matrix  proved  to  be  useful  in  that  it 
protected the material inside from the mechanical shock as- 
sociated with repeated centrifugation,  although it appeared 
to present no barrier to the extraction of detergent-soluble 
proteins. This was crucial to the procedure as demonstrated 
by the fact that,  when the  same extraction procedures de- 
scribed below are applied to true protoplasts (devoid of all 
cell  wall  material),  the  remaining  material becomes con- 
densed and intractable to further manipulation or analysis. 
Accordingly,  spheroplasts  were  prepared  and  extracted 
with 0.2%  Triton X-100 according to a  modification of the 
procedure of Heuser and Kirschner (13) followed by treat- 
ment with DNase I as described in Materials and Methods. 
Such  structures  rapidly lose most of their protein content 
(Fig. 4). Fig. 4 A summarizes the gross biochemical results 
of detergent extraction of spheroplasts. Proteins from whole 
yeast  cells,  Triton  X-100  extraction  supernatant,  and  ex- 
tracted cytoplasmic matrices were analyzed by SDS-POly- 
acrylamide gel electrophoresis.  Lanes 2  and 3,  equal cell 
equivalents of whole-cell lysate and detergent supernatant, 
respectively, indicate that all of the most abundant cellular 
proteins are accounted  for quantitatively  in  the  extraction 
supernatant.  Lane  4  contains  an  equal  cell  equivalent  of 
detergent-insoluble cytoplasmic matrices and serves to dem- 
onstrate that most of the cellular protein has been removed 
in  the  process.  Lane  1  displays  an  approximate  protein 
equivalent of the matrix sample. It is obvious that the cyto- 
plasmic matrix is  composed of a  small number of major 
polypeptides and a larger number of minor species. Further- 
more, several of the proteins enriched in the matrix fraction 
(lane 1 ) are visibly depleted in the supernatant fraction (lane 
3).  The  polypeptide composition of the  matrix bears  no 
resemblance to that seen for whole cells and close scrutiny 
of individual bands suggests that most of the principal matrix 
species are, at best, minor species in the cell, but are highly 
enriched in this structure.  The identifies of the majority of 
polypeptides present in the cytoplasmic matrix fraction are 
The Journal of Cell Biology, Volume  105, 1987  1532 Figure 5. Characterization of  yeast cytoplasmic matrices. (a) Detergent-extracted spheroplasts prior to DNase I digestion stained with DAPI. 
Chromatin is seen as a diffusely stained area in cytoplasmic matrices. (b) Detergent-extracted, DNAse I-treated cytoplasmic matrices stained 
with DAPI. (c) Detergent-extracted, DNase I-treated cytoplasmic matrices stained with rhodamine-phalloidin. (d and e) Electron micro- 
graphs of whole mounts of critical-point-dried cytoplasmic matrices. Bars: (a-c) 5 Ixm; (d and e) 1 and 0.1  Ixm. 
unknown. The majority of tubulin is lost during the prepara- 
tion of  these structures (de Barros Lopes, M., C. Wittenberg, 
and S.  Reed, unpublished observations). Fluorescence mi- 
croscopy using the DNA-specific dye DAPI indicates that a 
significant portion, if not all of, the nuclear DNA remains 
in the structures prior to treatment with DNase I (Fig. 5 a). 
Treatment with DNAse I,  a  procedure routinely incorpo- 
rated into our preparation of insoluble cytoplasmic matrices, 
removes the DNA (Fig. 5 b), thus averting the concern that 
chromatin in the structures might contribute to nonspecific 
adhesion of soluble proteins. 
The presence of actin in  these  cytoplasmic matrices is 
demonstrated both by fluorescence microscopy using rhoda- 
mine-tagged phalloidin  (Fig.  5  c)  and by immunoblotting 
(discussed below). An organized network of detergent-resis- 
tant  actin bundles  is  observed.  Cortical actin spots,  seen 
when whole, fixed cells are stained (1,  19, 26, 32), are not 
seen in cytoplasmic matrices. The reason for this selective 
extraction is not known.  The presence of actin is demon- 
strated on a biochemical level by immunoblots of whole-cell 
and cytoplasmic matrix polypeptides reacted with anti-yeast 
actin antiserum.  Such an experiment is shown in Fig. 4  B 
(lanes 1 and 2). A strongly reacting band is observed in both 
whole-cell and cytoplasmic matrix preparations which comi- 
grates with vertebrate actin as previously demonstrated for 
authentic yeast actin by Greer and Scheckman (10). This re- 
sult  corroborates those  observed with  rhodamine-labeled 
phalloidin. DNase I treatment has no significant effect on the 
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cytoplasmic  matrices. (a) Cytoplasmic  matrix prep- 
aration stained with affinity-purified  anti-CDC28 
product IgG. (b) Cytoplasmic matrix preparation 
stained with normal rabbit IgG. (c) Cytoplasmic 
matrix preparation stained with anti-yeast ADH 
serum. (d) Cytoplasmic matrix preparation stained 
with anti-ADH preiramune serum.  Second anti- 
body in all cases is fluorescein-conjugated  (FITC) 
affinity-purified  goat anti-rabbit IgG. Bars, 10 vtm. 
actin signal on immunoblots or on the structure observed by 
fluorescence microscopy with rhodamine-tagged phaUoidin 
(see Discussion). 
To confirm that the cytoplasmic matrices are devoid of 
soluble proteins, and that a protein known to be soluble does 
not form a stable association with them, matrices were exam- 
ined for the presence of ADH by immunoblotting. The re- 
suits of an experiment comparing the level of ADH in whole- 
cell and cytoplasmic matrix extracts is shown in Fig. 4 B, 
lanes 3 and 4. Proteins extracted from whole cells (lane 3) 
react strongly with the anti-ADH antisera while there is no 
detectable ADH signal in cytoplasmic matrices from three 
times as many cells (lane 4). We estimate that <0.1% of the 
amount of ADH present in whole cells could have been de- 
tected by this analysis. 
The structure of these cytoplasmic matrices is  revealed 
most clearly by preparing whole mounts after critical point 
drying and observing by EM (Fig. 5, d and e). This proce- 
dure is considered to conserve the three-dimensional struc- 
ture of vertebrate cytoskeletons and to allow for clear visual- 
ization of spatial relationships (43).  A  cytoplasmic matrix 
visualized in this manner is shown in Fig. 5, d and e. One 
observes a complex network of  filamentous material revealed 
by the complete removal of the cell wall surrounding the new 
cell bud. Cell wall material obscures the majority of the cell 
depicted in Fig. 5 d. Most of the cells in these preparations 
display only occasional gaps revealing the internal structure. 
Further  ultrastructural  and  biochemical  analysis  of  this 
structure will be required to determine the organization and 
composition of these matrices. 
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in Cytoplasmic Matrices 
To determine whether the CDC28 gene product is associated 
with detergent extracted cytoplasmic matrices, these struc- 
tures  were  prepared,  reacted  with  affinity-purified anti- 
CDC28~ product IgG and subjected to indirect immunofluo- 
rescence microscopy. Cytoplasmic matrices were also reacted 
with normal rabbit IgG and anti-ADH serum. The concen- 
trations  and  reaction  times  for all  immunologic  reagents 
were identical to those used in experiments with whole fixed 
cells.  Fig.  6, a  and b,  respectively, shows cytoplasmic ma- 
trices stained with anti-CDC28f product IgG and the nor- 
mal  IgG control.  The matrices display  a  staining  pattern 
similar to that seen for whole cells.  For reasons to be dis- 
cussed below, we do not feel that quantitative conclusions are 
justifed from this experiment although the level of staining 
appears  to be roughly comparable.  Cytoplasmic  matrices 
reacted with anti-ADH and corresponding preimmune sera 
show no staining (Fig.  6, c and d,  respectively). This lack 
of staining is consistent with the observation by immunoblot- 
ting that ADH, being a soluble cytoplasmic protein, does not 
have a strong affinity for insoluble cytoplasmic elements. On 
the other hand, one may conclude that at least a fraction of 
the CDC28 product is tightly associated with the cytoplasmic 
matrix and that this association is resistant to repeated and 
lengthy detergent extractions. 
In order to assess the association of the CDC28 product 
with the cytoplasmic matrix using a different criterion, im- 
munoblotting  experiments  were  performed  using  anti- 
CDC2828~_298 product  IgG.  This  antiserum  was  of higher 
titer than the anti-CDC28f sera and could be used in immu- 
noblotting experiments at a lower concentration without loss 
of signal.  This  is  an  advantage  in  that  nonspecific back- 
ground is decreased at lower antisera concentrations. Cyto- 
plasmic matrices were prepared as described. Immunoblots 
were prepared from SDS-polyacrylamide gels of whole-cell 
and cytoplasmic matrix polypeptides using antisera directed 
against the CDC28 gene product (anti-CDC2828j_298) either 
alone or preincubated with the peptide antigen as a blocking 
agent. The result of such an experiment is shown in Fig. 7 
(lanes 1-4). The presence of  the 34-kD CDC28 gene product 
in the cytoplasmic matrices is indicated by the comigration 
of the band  in both whole cells and cytoskeletal matrices 
(lanes 1 and 2, respectively). The 34-kD band in both lanes 
is blocked by the peptide antigen, confirming that the signal 
is due to the specific interaction between the antiserum and 
the  polypeptide.  The  whole-cell  lane  contains  a  second 
unidentified band which is also blocked by the peptide anti- 
gen. The intensity of this band varies between preparations. 
This could represent a  polypeptide related to the  CDC28 
gene product at the carboxy terminus, a modified form of the 
CDC28 product or the CDC28 polypeptide in complex with 
other molecules. The only modified forms of  the CDC28 that 
we  have observed are phosphorylated forms which comi- 
grate  with  the  unphosphorylated form on SDS-polyacryl- 
amide gels (Hadwiger, J., and S. Reed, unpublished observa- 
tions). 
Quantitation of the proportion of the CDC28 gene product 
in the cytoplasmic matrix is complicated by a number of fac- 
tors, the most substantial of which are the difficulties in de- 
termining the yield of matrices and in controlling proteoly- 
Figure 7. Immunoblotting analysis of CDC28 product in cytoplas- 
mic matrices. Sample preparation, electrophoresis, and immuno- 
blotting  were as  described.  Whole-cell  and cytoplasmic matrix 
samples (2 x  107 and 6 x  107 cells/lane, respectively) were stained 
with affinity purified anti-CDC28281_298 IgG  (lanes 1 and 2,  re- 
spectively) or with the same antibody blocked by preincubation 
with 0.5 ltg/ml of the peptide antigen (lanes 3 and 4, respectively). 
The position of the CDC28 gene product on the gel is denoted 
(pCDC2S). Molecular weight standards were the same as those given 
in Fig. 4. Values given are  xl0  -3. 
sis. There is variability between preparations of cytoplasmic 
matrices in the yield of CDC28 gene product as well as the 
ratio of actin to CDC28 gene product. With consideration for 
these limitations, the upper and lower limits for the propor- 
tion of CDC28 gene product associated with the cytoplasmic 
matrix when prepared in the manner described are 15 % and 
2 %, respectively. A portion of the remaining CDC28 gene 
product can be detected in the dialyzed supernatant of the 
first Triton X-100 extraction by immunoblotting (data  not 
shown). Actin association with the cytoplasmic matrix ranges 
from '~10% to 40% of the whole cell level. Presumably, a 
portion of the actin associated with the "cortical dots" (1, 19) 
as well as any soluble actin is lost during the preparation of 
the cytoplasmic matrices. Neither the CDC28 gene product 
nor actin is affected by the DNase I digestion used to prepare 
the insoluble cytoplasmic matrices (data not shown). 
It is notable that when the insoluble fraction is isolated by 
centrifugation of lysates from yeast spheroplasts mechani- 
cally disrupted in buffer with or without detergent, approxi- 
mately the same proportion of the CDC28 gene product is 
recovered as in cytoplasmic matrices (data not shown). The 
portion remaining in the supernatant is not sedimented by 
centrifugation at 100,000 g for 90 min and can, therefore, be 
considered truly soluble. This is in strong contrast to the rel- 
atively large proportion of the gene product found in the par- 
ticulate fraction when whole non-pretreated cells are simi- 
larly disrupted (Fig. 3). This argues that the association of 
the  CDC28 gene product with  the  particulate  fraction is 
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process. The finding that approximately the same proportion 
of  the gene product is associated with the particulate fraction 
in the presence or absence of detergent further supports the 
argument that this association is not due to a surface artifact. 
Discussion 
These results indicate that the majority of  the CDC28 protein 
kinase of S. cerevisiae resides in the cytoplasmic compart- 
ment and that at least a portion of  it is tightly associated with 
the insoluble cytoplasmic matrix. Cytoplasmic localization 
was demonstrated by indirect-immunofluorescence studies. 
Due to the small size of yeast cells and nuclei, in particular, 
we cannot eliminate the possibility that this protein is present 
in the nucleus as well. Such resolution must await immuno- 
cytochemical analysis at the electron microscopic level. 
The localization of  the CDC28 gene product within the cy- 
toplasmic compartment has been examined using several ap- 
proaches. First, the distribution of the gene product within 
particulate and soluble fractions of mechanically disrupted 
whole ceils was determined by immunoblotting. The mate- 
rial in the particulate fraction is unlikely to be membrane as- 
sociated in that it is not extractable by concentration of  Triton 
X-100 as high as 2 %. 
To refine the localization of  this particulate fraction further 
within the cytoplasm, a detergent-resistant fraction of yeast 
spheroplasts was prepared.  We refer to this fraction as the 
insoluble  cytoplasmic matrix.  Based  on  immunofluores- 
cence, it would appear that the majority of the CDC28 prod- 
uct is matrix bound. However, it is conceivable that matrices, 
which are of low density and are not aldehyde fixed in our 
procedure, are more accessible and reactive with antibodies 
than are prefixed, whole yeast ceils. As a result, quantitative 
assessments are probably not justified. On the other hand, 
based on immunoblotting experiments, it appears that only 
a fraction (2-15 %) of the CDC28 product is in the detergent- 
resistant fraction of spheroplasts. 
We cannot be certain that our recovery of cytoplasmic ma- 
trices  is  quantitative and  to  what extent  they have  been 
damaged. Rhodamine-phalloidin staining and immunoblot- 
ting of protein extracts of whole cells versus cytoskeletons 
suggests that a considerable portion of  actin is lost during our 
extraction procedure (as much as 90%).  It is possible that 
extractable and nonextractable actin represent biochemically 
distinct populations. This hypothesis is supported by our ob- 
servation that so-called cortical actin spots seen in stained 
whole  cells  (1,  19)  are  not seen  in  stained cytoskeletons 
whereas filamentous actin appears to be conserved (Fig. 5 
c). It is also likely, however, that there has been a systematic 
loss of cytoskeletal proteins during the extraction procedure. 
With respect to this point, we have observed that the variabil- 
ity in the extent of association between the  CDC28 gene 
product and the detergent-resistant matrix correlates well 
with the extent to which those matrices have become proteo- 
lyzed during their preparation.  Proteolysis varies between 
preparations as evidenced by a relatively low yield of high 
molecular weight polypeptides in some preparations based 
on  analysis  by  SDS-polyacrylamide  gel  electrophoresis. 
Although precautions have been taken,  the  sensitivity of 
cytoplasmic matrices to proteolysis and the abundance of 
proteases in yeast pose a formidable barrier to precise quan- 
titation (29). 
Finally, the CDC28 product may be largely matrix-associ- 
ated in a manner which is affected by the spheroplasting pro- 
cess. The presence of  >70% of  the gene product in the partic- 
ulate fraction when whole cells are disrupted under buffer 
and detergent conditions similar to those used for the prepa- 
ration of insoluble cytoplasmic matrices and the differences 
observed between spheroplasted and nonspheroplasted cells 
(discussed further below) suggest that a larger portion of the 
gene product may, in fact, be associated with the matrix in 
living cells. The nature of this effect is unclear at present. 
The loss observed during the preparation of cytoplasmic ma- 
trices cannot be explained simply by association with cell 
wall  debris  because  the  spheroplasts  retain  a  significant 
proportion of their cell wall (Fig. 5 d).  Considering these 
complications, it is clear that absolute quantitation of matrix 
association of  the CDC28 product must await further investi- 
gation. 
Treatment of  detergent-extracted spheroplasts with DNase 
I has not been observed to affect the proportion of actin or 
CDC28 gene product with the insoluble material. The ab- 
sence of an effect on actin content and structure, at least so 
far as can be discerned by rhodamine-phalloidin staining, is 
surprising in light of the ability of actin to specifically bind 
to DNase I (10) and the observation that DNase I can induce 
depolymerization of F-actin  under  some  conditions (14). 
Clearly, actin, in the state present in these matrices, either 
does not interact with DNase I or, at least, is not affected by 
such interaction. Similar observations have been made con- 
cerning DNase I treatment of vertebrate cytoskeletal prepa- 
rations (7). 
It is not clear at the moment whether association of the 
CDC28 product with the cytoplasmic matrix has any quan- 
titative meaning or biological significance. A cytoskeleton- 
related function for the CDC28 protein kinase is consistent 
with a number of experimental observations. G1 arrest con- 
ferred by cdc28 mutations is accompanied by a number of 
gross morphologic changes.  Most notably, cell growth is 
asymmetric in the absence of budding, causing a loss of the 
normal spheroid shape and a transition to large amorphous 
cells often called "shmoos" (9, 30). Such extreme changes of 
form must involve cytoskeletal interactions at some level. 
This is confirmed by observing the structure of  actin in cdc28 
mutants. Shortly after a shift of temperature sensitive cdc28 
mutants to the restrictive temperature, we have observed the 
disintegration of  actin fibers and the concomitant appearance 
of apparently disorganized actin foci (32). We, of course, do 
not know whether this effect of cdc28 dysfunction on actin 
structure is direct, but it serves to underscore an inherent 
relationship of the cdc28 phenotype to cytoskeletal compo- 
nents. Similar alterations in actin structure are observed in 
temperature-sensitive actin mutants at the restrictive temper- 
ature (26).  Another phenotype conferred by cdc28 mutants 
is a defect in nuclear fusion (karyogamy) during conjugation 
(9).  Initial  reports  described  a  unilateral kar defect (9), 
meaning that only one parent need be mutant, to observe the 
effect on conjugation for cdc28 mutants. We have recently 
found, however, that in our strains, both conjugants need to 
be cdc28 mutants (bilateral kar defect; unpublished observa- 
tions). Mutant zygotes stained using DAPI in order to visual- 
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observations). It is expected that organdie motility involves 
cytoskeletal  function (42). 
We report the preparation  of detergent-resistant  cytoplas- 
mic matrices from yeast spheroplasts by a procedure adapted 
from a regime developed for the preparation of cytoskeletons 
from vertebrate  cells (13). A preliminary ultrastructural  and 
biochemical analysis of the resulting structures  is presented. 
If the complete extraction of alcohol dehydrogenase is an ac- 
curate  criterion, these structures  are devoid of soluble pro- 
teins. The procedure results in a complex three-dimensional 
structure which conserves the structure of the actin "cage" re- 
vealed by rhodamine-phalloidin staining of whole cells. As 
is the case with vertebrate cells, only a limited subset of pro- 
teins is retained  during the course of the extraction proce- 
dure.  Evidence  is  presented  that  one  of  these  is  actin, 
Filamentous structures  of several different forms are recog- 
nizable in electron micrographs. One of these is likely to be 
actin  filaments.  Another  form  appears  to  have  a  tubular 
structure  similar to known vertebrate  cytoskeletal elements 
such  as  microtubules  and  intermediate  filaments.  At  this 
time, there is no strong evidence for the existence in yeast 
of intermediate filaments, a major constituent of vertebrate 
cytoskeletons (21).  Our structures  do not contain significant 
amounts of tubulin, as is expected because extractions were 
not  carried  out  under  conditions  necessary  to  stabilize 
microtubules.  Similar procedures which preserve microtu- 
bule structure  have been adapted  for use with S.  cerevisiae 
(28). The procedure we have developed makes use of the re- 
sidual cell wall to protect the cytoplasmic matrices from me- 
chanical  shock associated  with centrifugal  washes.  It  was 
found that cytoplasmic matrices rapidly disintegrate  if cell 
walls are removed completely.  It is conceivable,  therefore, 
that some proteins retained  during our extraction procedure 
are wall-associated rather than  matrix associated. 
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